Investment analysts at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for Prime Medicine in a ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Prime Medicine, Inc. (PRME – Research Report), ...

H.C. Wainwright analyst Arthur He CFA maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report) today and set a price target of $10.00. Arthur He CFA has given his Buy rating due to a ...

So, the natural question for Prime Medicine (NASDAQ:PRME) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the annual rate ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...

On Monday, Prime Medicine Inc (PRME) stock saw a modest uptick, ending the day at $4.39 which represents a slight increase of $0.29 or 7.07% from the prior close of $4.1. The stock opened at $4.23 and ...

Prime Medicine, Inc. ( (PRME)) has released its Q3 earnings. Here is a breakdown of the information Prime Medicine, Inc. presented to its investors. Prime Medicine, Inc. is a biotechnology company ...

Reports Q3 revenue $209K, consensus $7.83M…In September 2024, Prime Medicine (PRME) entered into a strategic research collaboration and license agreement with Bristol Myers Squibb to develop and ...

Japan's top government spokesman said a dose of cold medicine was to blame for causing a slightly ill Prime Minister Shigeru ...

Prime Minister Justin Trudeau says the federal government could have acted faster on reining in immigration programs, after ...

Japanese social media was quick to point out that PM Shigeru Ishiba appeared to doze off during Monday’s vote in parliament ...

The prime minister's recent episode at the Japanese parliament raised some eyebrows, with people wondering if there is a ...